Creo Medical Group (CREO)

Sector:

Health Care

Index:

FTSE AIM All-Share

12.25p
   
  • Change Today:
      0.63p
  • 52 Week High: 19.75
  • 52 Week Low: 9.55
  • Currency: UK Pounds
  • Shares Issued: 412.47m
  • Volume: 2,882,174
  • Market Cap: £50.53m
  • Beta: 0.56

CREO Overview

Creo Medical was founded in 2003 as MicroOncology Ltd by Professor Chris Hancock, initially to target the treatment of cancers through use of high frequency microwave energy and dynamic matching techniques.

Key Personnel

CEO: Craig Jonathan Gulliford
CFO: Richard John Rees
Chairman: Kevin Crofton
Independent Non-Executive Director: Brent Boucher
Independent Non-Executive Director: Ivonne Cantu
Non-Executive Dir:

Contact Details

Address: Creo House, Unit 2 Beaufort Park, Beaufort Park Way, Chepstow, Wales, United Kingdom , NP16 5UH
Phone: +44 (0) 1291 606005
Website: http://creomedical.com/

Listings

Sector: Health Care(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BZ1BLL44

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

CREO Market Data

Currency UK Pounds
Share Price 12.25p
Change Today 0.63p
% Change 5.38 %
52 Week High 19.75
52 Week Low 9.55
Volume 2,882,174
Shares Issued 412.47m
Market Cap £50.53m
Beta 0.56

CREO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
5.70% above the market average5.70% above the market average5.70% above the market average5.70% above the market average5.70% above the market average
9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average
Price Trend
76.94% below the market average76.94% below the market average76.94% below the market average76.94% below the market average76.94% below the market average
31.43% below the sector average31.43% below the sector average31.43% below the sector average31.43% below the sector average31.43% below the sector average
Income Not Available
Growth
46.91% below the market average46.91% below the market average46.91% below the market average46.91% below the market average46.91% below the market average
65.71% below the sector average65.71% below the sector average65.71% below the sector average65.71% below the sector average65.71% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CREO Dividends

No dividends found

Trades for 19-Jan-2026

Time Volume / Share Price
17:08 4,500 @ 12.25p
16:19 40,000 @ 12.06p
15:39 4,500 @ 12.16p
15:32 15,000 @ 12.16p
15:31 1 @ 12.20p

CREO Key Personnel

CEO Craig Jonathan Gulliford
CFO Richard John Rees
Chair Kevin Crofton

Top of Page